ArticleInsect molecular biology2026
Transcriptomic, proteomic and biochemical comparison of luminescent and non-luminescent Keroplatinae larvae (Diptera: Keroplatidae).
Article in Insect molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptomic, proteomic and biochemical comparison of luminescent and non-luminescent Keroplatinae larvae (Diptera: Keroplatidae).Insect molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bioluminescence (BL) in the Keroplatinae subfamily (Diptera: Keroplatidae) is found in Keroplatus, Neoceroplatus and Orfelia fultoni larvae. In O. fultoni, BL involves an oligomeric luciferase, a luciferin called keroplatin, which is associated with a substrate binding fraction (SBF), whose molecular identity and function remain uncertain. Non-luminescent web-constructing predatory larvae of Neoditomyia sp. (Keroplatinae) also contain keroplatin and SBF in their bodies, suggesting additional unknown roles for this compound in this subfamily. To identify gene products differentially expressed between luminescent and non-luminescent larvae, especially those associated with luciferase, SBF and keroplatin synthesis, here we compared the transcriptional and proteomic profiles of Neoditomyia sp., O. fultoni and Arachnocampa larvae and conducted biochemical assays. Similarly to O. fultoni, Neoditomyia sp. displays an abundance of hexamerin isoforms and transcripts associated with the tryptophan and kynurenine pathway, which is potentially involved with keroplatin synthesis and silk production. Despite displaying a similar electrophoretic pattern of Orfelia luciferase purified fractions, no luciferase activity was detected in Neoditomyia purified fractions. The SBF-enriched fractions from O. fultoni and Neoditomyia revealed a similar abundance of hexamerins, the presence of flavin-dependent reductases, keroplatin and riboflavin. The results indicate that the SBF consists of protein aggregates associated with riboflavin and keroplatin, which is used as luciferin in bioluminescent species and for other still unveiled physiological functions in non-luminescent species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.